F. A. Anderer

3.3k total citations
128 papers, 2.6k citations indexed

About

F. A. Anderer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, F. A. Anderer has authored 128 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 33 papers in Immunology and 30 papers in Oncology. Recurrent topics in F. A. Anderer's work include Plant Virus Research Studies (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Transgenic Plants and Applications (17 papers). F. A. Anderer is often cited by papers focused on Plant Virus Research Studies (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers) and Transgenic Plants and Applications (17 papers). F. A. Anderer collaborates with scholars based in Germany. F. A. Anderer's co-authors include H. D. Schlumberger, H. J. Staab, Rainer Fischer, E. Stumpf, Edgar A. Mueller, Julian N. Kanfer, Martin Pfaff, Edit Wéber, Maximilian Koch and H. Frank and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

F. A. Anderer

125 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. A. Anderer Germany 29 1.2k 553 511 435 392 128 2.6k
Séverine Frutiger Switzerland 29 2.2k 1.8× 402 0.7× 264 0.5× 405 0.9× 126 0.3× 49 3.5k
Richard C. Najarian United States 15 1.4k 1.1× 287 0.5× 253 0.5× 474 1.1× 122 0.3× 16 3.1k
Yoshio Okada Japan 33 2.6k 2.1× 413 0.7× 235 0.5× 987 2.3× 248 0.6× 212 4.4k
James L. Hartley United States 26 4.0k 3.3× 457 0.8× 466 0.9× 264 0.6× 389 1.0× 48 5.5k
E. Benjamini United States 26 1.3k 1.0× 138 0.2× 197 0.4× 365 0.8× 126 0.3× 84 2.5k
Kathleen M. Downey United States 36 3.4k 2.7× 756 1.4× 275 0.5× 233 0.5× 227 0.6× 63 4.6k
Maria Gallo United States 27 1.1k 0.9× 212 0.4× 103 0.2× 423 1.0× 137 0.3× 65 2.2k
Lloyd Waxman United States 36 2.2k 1.8× 469 0.8× 139 0.3× 317 0.7× 136 0.3× 65 3.9k
Shelby L. Berger United States 27 1.9k 1.6× 402 0.7× 193 0.4× 730 1.7× 117 0.3× 53 3.1k
Thomas Grundström Sweden 39 3.2k 2.6× 493 0.9× 347 0.7× 836 1.9× 335 0.9× 95 5.1k

Countries citing papers authored by F. A. Anderer

Since Specialization
Citations

This map shows the geographic impact of F. A. Anderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. A. Anderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. A. Anderer more than expected).

Fields of papers citing papers by F. A. Anderer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. A. Anderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. A. Anderer. The network helps show where F. A. Anderer may publish in the future.

Co-authorship network of co-authors of F. A. Anderer

This figure shows the co-authorship network connecting the top 25 collaborators of F. A. Anderer. A scholar is included among the top collaborators of F. A. Anderer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. A. Anderer. F. A. Anderer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderer, F. A., et al.. (1996). Enhancement of Human NK and LAK Cytotoxicity against HCMV-Infected Cells by Rhamnogalacturonan: Specificity of Reaction. Viral Immunology. 9(1). 27–34. 4 indexed citations
2.
3.
Zhu, Hongguang, et al.. (1995). Chemospecificity and Cross‐Reactivity of Target Cell Recognition by Human CD56+ NK and LAK Cells. Scandinavian Journal of Immunology. 41(6). 545–552.
4.
Anderer, F. A., et al.. (1994). Structural Specificity of MHC‐Unrestricted Recognition of HCMV‐Infected Target Cells by Human CD56+NK and LAK Cells. Scandinavian Journal of Immunology. 40(6). 665–668. 1 indexed citations
5.
Anderer, F. A., et al.. (1994). Identification of a mannose-acetate-specific 87-kDa receptor responsible for human NK and LAK activity. Immunology Letters. 42(1-2). 7–12. 12 indexed citations
6.
Zhu, Hongguang, Thomas M. Zollner, Andreas Klein‐Franke, & F. A. Anderer. (1993). Activation of human monocyte/macrophage cytotoxicity by IL-2/IFNγ is linked to increased expression of an antitumor receptor with specificity for acetylated mannose. Immunology Letters. 38(2). 111–119. 9 indexed citations
7.
Anderer, F. A., et al.. (1993). Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan fromLarix occidentalis. Cancer Immunology Immunotherapy. 36(4). 237–244. 58 indexed citations
8.
Anderer, F. A., et al.. (1992). The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon γ. Cancer Immunology Immunotherapy. 34(5). 299–305. 4 indexed citations
9.
Hamprecht, Klaus & F. A. Anderer. (1990). Autolytic generation of dialyzable components in extracts of viscum album exhibiting different mechanisms of enhancement of human nk cytotoxicity against tumor cells. International Journal of Immunopathology and Pharmacology. 3(2). 63–74. 1 indexed citations
10.
Mueller, Edgar A. & F. A. Anderer. (1990). Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cells. Immunopharmacology. 19(1). 69–77. 24 indexed citations
11.
Mueller, Edgar A. & F. A. Anderer. (1990). AViscum album oligosaccharide activating human natural cytotoxicity is an interferon γ inducer. Cancer Immunology Immunotherapy. 32(4). 221–227. 61 indexed citations
12.
Mueller, Edgar A., Klaus Hamprecht, & F. A. Anderer. (1989). Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicity. Immunopharmacology. 17(1). 11–18. 25 indexed citations
13.
Hamprecht, Klaus, W. Vötsch, & F. A. Anderer. (1989). A Dialysable Acid Factor from Human Leukocyte Extracts Activates Tumor Cell Lysis Mediated by Human Monocytes and Natural Killer Cells. Oncology Research and Treatment. 12(3). 120–127. 5 indexed citations
14.
Pfaff, Martin, et al.. (1988). Autoimmune expression of a cytoplasmic protein p60 in mice bearing metastasizing SV40‐transformed tumors. International Journal of Cancer. 42(6). 906–912. 1 indexed citations
15.
Pfaff, Martin & F. A. Anderer. (1988). Casein kinase II accumulation in the nucleolus and its role in nucleolar phosphorylation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 969(1). 100–109. 65 indexed citations
16.
Anderer, F. A., et al.. (1987). Human SS-B/LA autoantigen contains a covalent protein-RNA linkage. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 909(3). 173–182. 3 indexed citations
17.
Anderer, F. A., et al.. (1986). Characterisation of nucleolar proteins as autoantigens using human autoimmune sera.. Annals of the Rheumatic Diseases. 45(12). 978–986. 26 indexed citations
18.
Anderer, F. A., et al.. (1965). [Cross reactions of antiserums against heterologous terminal amino acid sequences and two strains of the tobacco mosaic virus].. PubMed. 20(6). 564–8. 13 indexed citations
19.
Anderer, F. A., B. Wittmann-Liebold, & H. G. Wittmann. (1965). Weitere Untersuchungen zur Aminosäuresequenz des Proteins im Tabakmosaikvirus. Zeitschrift für Naturforschung B. 20(12). 1203–1213. 47 indexed citations
20.
Anderer, F. A., et al.. (1960). Primary Structure of the Protein of Tobacco Mosaic Virus. Nature. 186(4729). 922–925. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Séverine Frutiger Breakdown of academic impact, for papers by Richard C. Najarian Breakdown of academic impact, for papers by Yoshio Okada Breakdown of academic impact, for papers by James L. Hartley Breakdown of academic impact, for papers by E. Benjamini Breakdown of academic impact, for papers by Kathleen M. Downey Breakdown of academic impact, for papers by Maria Gallo Breakdown of academic impact, for papers by Lloyd Waxman Breakdown of academic impact, for papers by Shelby L. Berger Breakdown of academic impact, for papers by Thomas Grundström
Rankless by CCL
2026